CDIOW

Cardio Diagnostics Holdings Inc. [CDIOW] represents warrants that give holders the right, but not the obligation, to purchase shares of Cardio Diagnostics common stock at a predetermined exercise price before a specified expiration date. Warrants are derivative securities that provide leverage and additional upside potential compared to owning the underlying stock directly. These warrants were likely issued in connection with Cardio Diagnostics' public offering or business combination. The underlying company, Cardio Diagnostics Holdings Inc., is a precision cardiovascular medicine firm headquartered in Chicago, Illinois, that develops AI-powered genetic tests for heart disease prevention. Warrant holders can benefit from increases in the stock price above the exercise price without requiring the full capital investment needed to purchase shares outright. However, warrants carry expiration risk and may expire worthless if the stock price remains below the exercise price. The trading characteristics and volatility of warrants typically differ from the underlying common stock.